Effective gene therapy without side effects for inflammatory bowel diseases – Targeted delivery of LNA by lipid nanoparticles
Researchers develop a new approach for treating inflammatory bowel diseases by delivering locked nucleic acids (LNAs) to the relevant organ using lipid nanoparticles. The study shows improvement in inflammation markers with no side effects, paving the way for potential treatments of rare genetic disorders and other diseases.